Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (loss)	Accumulated Deficit
Balance at the beginning of the period (in shares) at Dec. 31, 2022		541,364,000
Balance at the beginning of the period at Dec. 31, 2022	$ 1,472,956	$ 53	$ 2,082,373	$ (7,237)	$ (602,233)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of options (in shares)		803,000
Issuance of common stock upon exercise of options	1,051		1,051
Issuance of common stock net settlement of restricted stock units (in shares)		1,470,000
Issuance of common stock upon net settlement of restricted stock units	(3,746)		(3,746)
Vesting of common stock warrants	2,102		2,102
Share-based compensation	33,906		33,906
Executive chairman long-term performance award	13,121		13,121
Repurchase and retirement of common stock, including excise tax (in shares)		(3,206,000)
Repurchase and retirement of common stock, including excise tax	(20,993)		(20,993)
Change in accumulated other comprehensive income (loss)	4,054			4,054
Net income (loss)	(68,801)				(68,801)
Balance at the end of the period (in shares) at Mar. 31, 2023		540,432,000
Balance at the end of the period at Mar. 31, 2023	1,433,650	$ 53	2,107,814	(3,183)	(671,034)
Balance at the beginning of the period (in shares) at Dec. 31, 2022		541,364,000
Balance at the beginning of the period at Dec. 31, 2022	1,472,956	$ 53	2,082,373	(7,237)	(602,233)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Change in accumulated other comprehensive income (loss)	5,399
Net income (loss)	(182,587)
Balance at the end of the period (in shares) at Sep. 30, 2023		526,586,000
Balance at the end of the period at Sep. 30, 2023	1,295,083	$ 53	2,081,689	(1,838)	(784,821)
Balance at the beginning of the period (in shares) at Mar. 31, 2023		540,432,000
Balance at the beginning of the period at Mar. 31, 2023	1,433,650	$ 53	2,107,814	(3,183)	(671,034)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of options (in shares)		828,000
Issuance of common stock upon exercise of options	1,310		1,310
Issuance of common stock under employee stock purchase plan (in shares)		446,000
Issuance of common stock under employee stock purchase plan	1,775		1,775
Issuance of common stock net settlement of restricted stock units (in shares)		2,679,000
Issuance of common stock upon net settlement of restricted stock units	(6,324)		(6,324)
Vesting of common stock warrants	2,372		2,372
Share-based compensation	32,152		32,152
Executive chairman long-term performance award	13,267		13,267
Repurchase and retirement of common stock, including excise tax (in shares)		(10,168,000)
Repurchase and retirement of common stock, including excise tax	(48,497)	$ (1)	(48,496)
Change in accumulated other comprehensive income (loss)	1,707			1,707
Net income (loss)	(58,797)				(58,797)
Balance at the end of the period (in shares) at Jun. 30, 2023		534,217,000
Balance at the end of the period at Jun. 30, 2023	1,372,615	$ 52	2,103,870	(1,476)	(729,831)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of options (in shares)		1,189,000
Issuance of common stock upon exercise of options	1,675		1,675
Repurchase of early exercised stock options (in shares)		(3,000)
Repurchase of early exercised stock options	(6)		(6)
Issuance of common stock net settlement of restricted stock units (in shares)		2,645,000
Issuance of common stock upon net settlement of restricted stock units	(8,481)	$ 2	(8,483)
Vesting of common stock warrants	2,284		2,284
Share-based compensation	33,383		33,383
Executive chairman long-term performance award	13,413		13,413
Repurchase and retirement of common stock, including excise tax (in shares)		(11,463,000)
Repurchase and retirement of common stock, including excise tax	(64,448)	$ (1)	(64,447)
Change in accumulated other comprehensive income (loss)	(362)			(362)
Net income (loss)	(54,990)				(54,990)
Balance at the end of the period (in shares) at Sep. 30, 2023		526,586,000
Balance at the end of the period at Sep. 30, 2023	1,295,083	$ 53	2,081,689	(1,838)	(784,821)
Balance at the beginning of the period (in shares) at Dec. 31, 2023		520,343,000
Balance at the beginning of the period at Dec. 31, 2023	1,243,395	$ 52	2,067,776	762	(825,195)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of options (in shares)		98,000
Issuance of common stock upon exercise of options	49		49
Issuance of common stock net settlement of restricted stock units (in shares)		2,806,000
Issuance of common stock upon net settlement of restricted stock units	(10,917)		(10,917)
Vesting of common stock warrants	2,100		2,100
Share-based compensation	33,393		33,393
Executive chairman long-term performance award	13,121		13,121
Repurchase and retirement of common stock, including excise tax (in shares)		(5,238,000)
Repurchase and retirement of common stock, including excise tax	(32,830)		(32,830)
Change in accumulated other comprehensive income (loss)	(1,586)			(1,586)
Net income (loss)	(36,060)				(36,060)
Balance at the end of the period (in shares) at Mar. 31, 2024		518,009,000
Balance at the end of the period at Mar. 31, 2024	1,210,665	$ 52	2,072,692	(824)	(861,255)
Balance at the beginning of the period (in shares) at Dec. 31, 2023		520,343,000
Balance at the beginning of the period at Dec. 31, 2023	1,243,395	$ 52	2,067,776	762	(825,195)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Change in accumulated other comprehensive income (loss)	71
Net income (loss)	54,405
Balance at the end of the period (in shares) at Sep. 30, 2024		504,150,000
Balance at the end of the period at Sep. 30, 2024	1,095,658	$ 50	1,865,565	833	(770,790)
Balance at the beginning of the period (in shares) at Mar. 31, 2024		518,009,000
Balance at the beginning of the period at Mar. 31, 2024	1,210,665	$ 52	2,072,692	(824)	(861,255)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of options (in shares)		33,000
Issuance of common stock upon exercise of options	59		59
Issuance of common stock under employee stock purchase plan (in shares)		327,000
Issuance of common stock under employee stock purchase plan	1,629		1,629
Issuance of common stock net settlement of restricted stock units (in shares)		3,338,000
Issuance of common stock upon net settlement of restricted stock units	(9,370)		(9,370)
Share-based compensation	38,209		38,209
Executive chairman long-term performance award	(157,738)		(157,738)
Repurchase and retirement of common stock, including excise tax (in shares)		(10,959,000)
Repurchase and retirement of common stock, including excise tax	(59,738)	$ (1)	(59,737)
Change in accumulated other comprehensive income (loss)	(449)			(449)
Net income (loss)	119,108				119,108
Balance at the end of the period (in shares) at Jun. 30, 2024		510,748,000
Balance at the end of the period at Jun. 30, 2024	1,142,375	$ 51	1,885,744	(1,273)	(742,147)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of options (in shares)		11,000
Issuance of common stock upon exercise of options	13		13
Issuance of common stock net settlement of restricted stock units (in shares)		2,790,000
Issuance of common stock upon net settlement of restricted stock units	(8,756)		(8,756)
Vesting of common stock warrants	322		322
Share-based compensation	37,145		37,145
Repurchase and retirement of common stock, including excise tax (in shares)		(9,399,000)
Repurchase and retirement of common stock, including excise tax	(48,904)	$ (1)	(48,903)
Change in accumulated other comprehensive income (loss)	2,106			2,106
Net income (loss)	(28,643)				(28,643)
Balance at the end of the period (in shares) at Sep. 30, 2024		504,150,000
Balance at the end of the period at Sep. 30, 2024	$ 1,095,658	$ 50	$ 1,865,565	$ 833	$ (770,790)